Operating Profit Changement Date
Abbott USD 1.79B 119M 2023-12
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Acorda Therapeutics USD -3632000 7.84M 2023-06
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Illumina USD -164000000 590M 2023-12
Insmed USD -178272000 30.6M 2023-12
Ironwood Pharmaceuticals USD 37.59M 2.43M 2023-12
J&J USD 4.83B 391M 2023-12
Lexicon Pharmaceuticals USD -49631000 5.39M 2023-09
MannKind USD 7.86M 2.76M 2023-12
Merck USD -1933000000 7.68B 2023-12
Moderna USD 6M 2.02B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Thermo Fisher Scientific USD 1.85B 10M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06



Lexicon Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.